NEWS

Microviable received the Certificate of Innovative SME awarded by the Spanish Ministry "Ministerio de Ciencia, Innovación y Universidades". This certificate is an official recognition from the Ministry of the innovative work carried out by Microviable [...]

Microviable will be present at the National Symposium of the Spanish Society of Infectious Diseases and Clinical Microbiology ( SEIMC - Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica). From May 28-30, the SEIMC National [...]

Microviable Therapeutics SL  received funding under Eurostars-3 Program co-financed by CDTI (Spanish National Agency) and the Research and Innovation Funding Program Horizon Europe. The project “Microbiome-based medicinal products to increase the efficacy of immunotherapy” MICROBOOST, [...]

During May 18-20, the international event Pint of Science  invite leading scientists to share their knowledge in a relaxed and informal setting, in the bars! This provides a platform that allows people to learn about [...]

Microviable has been invited to give a lecture at the Symposium "Microbiome and Cancer: a translational axis in todays oncology", organized by Fundación Fisabio y and the Microbiome Hub. Noelia Martinez Alvarez y David Rios-Covian, [...]

Microviable has received the 2025 Microbiome Research Reports High-Impact Paper Award, a recognition to an outstanding scientific review manuscript published in 2025 in the journal Microbiome Research Reports. Our CTO, David Ríos Covián, PhD, lead [...]